Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Chemistry Outsourcing

Thomas Saunders's Biography

Thomas Saunders, Of Counsel, Rissman Hendricks & Oliverio

Thomas Saunders is Of Counsel in the law firm of Rissman Hendricks & Oliverio in Boston, Massachusetts. He specializes in representing biotechnology/genetic engineering and pharmaceutical concerns, particularly as to patent prosecution, licensing and litigation matters. Recent publications include “Latin American Patent Activity in the United States,” Beyond the First World, May 25, 2010;"Life Sciences Lawyering: Staying Within the MTD," Life Sciences Client Strategies, (Aspatore Books 2007), "India And China: New Frontiers In Pharma," CHEManager Europe, October 2006; “Patents as a Cash Crop: Sowing, Growing, Reaping & Litigating," Current Studies of Biotechnology, Vol. III, 381-385 (Croatian Society of Biotechnology and Medicinska Nakada Zagreb, Croatia 2003) “Technology Patents: ‘If you’ve got ‘em, flaunt ‘em’” Mass High Tech, February 3, 2003; “Translating European Biotech into US Patents: Do’s, Don’t’s & Costs,” Focus in Biotechnology, Volume IV Engineering and Manufacturing for Biotechnology, Eds. Marcel Hofman and Philippe Thonart (Kluwer, Dordrecht, the Netherlands 2001).

Thomas Saunders Image

U.S. Patent Law of 2011: The Good, The Bad, and The Expensive

Tuesday, 13 March 2012 at 14:15

Add to Calendar ▼2012-03-13 14:15:002012-03-13 15:15:00Europe/LondonU.S. Patent Law of 2011: The Good, The Bad, and The Expensive

In September of 2011, a significantly revised U.S. patent law was enacted. The new law includes the U.S. becoming a “first-to-file” country in 2013. A patent opposition system is also included in the new law. Highlights and costs of this new landscape will be examined along with new strategies.

Add to Calendar ▼2012-03-13 00:00:002012-03-14 00:00:00Europe/LondonChemistry